Overview

A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Clozapine is an antipsychotic. This open study will evaluate the safety and efficacy of long term treatment of clozapine in patients with treatment-resistant schizophrenia.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Clozapine